Market Cap N/A
Revenue (ttm) 0.00
Net Income (ttm) 0.00
EPS (ttm) N/A
PE Ratio N/A
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio N/A
Volume 1,370,000
Avg Vol 1,014,780
Day's Range N/A - N/A
Shares Out N/A
Stochastic %K 64%
Beta N/A
Analysts Strong Buy
Price Target N/A

Company Profile

Charlotte's Web Holdings, Inc. engages in the farming, manufacturing, marketing, and sale of hemp-derived cannabidiol (CBD) and other botanical-based wellness products. Its product categories include full-spectrum hemp extract oil tinctures, such as liquid products; gummies; capsules; soft-gels; CBD topical creams and lotions; broad-spectrum botanical CBD; functional mushrooms; and pet products under the Charlotte's Web, CBD CLINIC, and CBD MEDIC brand names. The company's products contain natur...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 720 484 8930
Address:
700 Tech Court, Louisville, United States
Judykay
Judykay Feb. 3 at 11:45 PM
$CWBHF I am starting a small position here.
0 · Reply
InvertedNegG
InvertedNegG Feb. 3 at 7:53 PM
$CWBHF I'll take another 1000 shares, thank you very much!
0 · Reply
buttbutt
buttbutt Feb. 3 at 6:11 PM
$CWBHF I cant tell the future audiophile but i believe buying at these levels are good, i bought dome this morning also.
0 · Reply
buttbutt
buttbutt Feb. 3 at 6:09 PM
$CWBHF down .10 on low volume. Dont sell now people. Its about to get interesting.
0 · Reply
audiopile
audiopile Feb. 3 at 6:08 PM
$CWBHF i bought this morning...
0 · Reply
buttbutt
buttbutt Feb. 3 at 6:06 PM
$CWBHF weak hands leaving. More stable hands buying in.
0 · Reply
Wavebike
Wavebike Feb. 3 at 6:00 PM
$CWBHF looking like a good level to add
0 · Reply
StonkCapital
StonkCapital Feb. 3 at 5:54 PM
$CWBHF now makes up 3.17% of $YOLOS holdings at the end of January and seems to be increasing over time. $MSOS $TLRY $HITI $ACB https://x.com/i/status/2018735427767722172
0 · Reply
MrBurp
MrBurp Feb. 3 at 5:00 PM
$CWBHF As reported by the scientific journal Drugs and Drug Candidates , the use of CBD and CBG in nanocapsules made of Eudragit L100 polymer has shown high efficacy in protecting the gut from inflammation, according to a new study by Mexican researchers. https://thecannex.com/nano-cbd-cbg-colitis-study-results/
0 · Reply
StonkCapital
StonkCapital Feb. 3 at 4:53 PM
$CWBHF Always does the opposite of the rest of the cannabis sector. When Charlottes Web turns green, I buy some $TLRY $MSOS $TCNNF $YOLO etc when they drop then take profits on them when CWEB drops and add more CWBHF because it has the brightest future in this space imo.
1 · Reply
Latest News on CWBHF
No data available.
Judykay
Judykay Feb. 3 at 11:45 PM
$CWBHF I am starting a small position here.
0 · Reply
InvertedNegG
InvertedNegG Feb. 3 at 7:53 PM
$CWBHF I'll take another 1000 shares, thank you very much!
0 · Reply
buttbutt
buttbutt Feb. 3 at 6:11 PM
$CWBHF I cant tell the future audiophile but i believe buying at these levels are good, i bought dome this morning also.
0 · Reply
buttbutt
buttbutt Feb. 3 at 6:09 PM
$CWBHF down .10 on low volume. Dont sell now people. Its about to get interesting.
0 · Reply
audiopile
audiopile Feb. 3 at 6:08 PM
$CWBHF i bought this morning...
0 · Reply
buttbutt
buttbutt Feb. 3 at 6:06 PM
$CWBHF weak hands leaving. More stable hands buying in.
0 · Reply
Wavebike
Wavebike Feb. 3 at 6:00 PM
$CWBHF looking like a good level to add
0 · Reply
StonkCapital
StonkCapital Feb. 3 at 5:54 PM
$CWBHF now makes up 3.17% of $YOLOS holdings at the end of January and seems to be increasing over time. $MSOS $TLRY $HITI $ACB https://x.com/i/status/2018735427767722172
0 · Reply
MrBurp
MrBurp Feb. 3 at 5:00 PM
$CWBHF As reported by the scientific journal Drugs and Drug Candidates , the use of CBD and CBG in nanocapsules made of Eudragit L100 polymer has shown high efficacy in protecting the gut from inflammation, according to a new study by Mexican researchers. https://thecannex.com/nano-cbd-cbg-colitis-study-results/
0 · Reply
StonkCapital
StonkCapital Feb. 3 at 4:53 PM
$CWBHF Always does the opposite of the rest of the cannabis sector. When Charlottes Web turns green, I buy some $TLRY $MSOS $TCNNF $YOLO etc when they drop then take profits on them when CWEB drops and add more CWBHF because it has the brightest future in this space imo.
1 · Reply
ricotta
ricotta Feb. 3 at 4:02 PM
$CWBHF can any level 2 watchers explain what OTCN and VIRT MMs are doing?? they actively box it- are /try to be on best bid and ask w constantly changing bids/asks- are they accumulating or selling? i cant figure it out
1 · Reply
buttbutt
buttbutt Feb. 3 at 4:02 PM
$CWBHF sorry wrong board.
0 · Reply
buttbutt
buttbutt Feb. 3 at 4:02 PM
$CWBHF Gotham report. Not true. Yep somethings brewing. Good earnings.
0 · Reply
Jamstrades
Jamstrades Feb. 3 at 2:37 PM
$CWBHF Hard to believe we have so few watchers. Need to start sharing this with other boards!
0 · Reply
ricotta
ricotta Feb. 3 at 2:05 PM
1 · Reply
StonkCapital
StonkCapital Feb. 3 at 12:56 PM
0 · Reply
buttbutt
buttbutt Feb. 3 at 12:47 PM
0 · Reply
sootman1
sootman1 Feb. 3 at 11:04 AM
0 · Reply
MWM
MWM Feb. 3 at 9:19 AM
$CWBHF I added a lot yesterday. Might hit it for more if it dips. Someone really trying to hold it in a range. I think $1 is coming quickly
0 · Reply
InvertedNegG
InvertedNegG Feb. 3 at 1:31 AM
$CWBHF If Charlotte’s Web (CWBHF) turns sustainably cash-flow positive in 2026, the market would likely re-rate the stock from a speculative turnaround to a viable small-cap consumer business. Based on a leaner cost structure, ~$75–85M in revenue, and typical post-breakeven multiples (roughly 1.5–2.0× sales), a reasonable settling range is ~$0.75–$1.10 per share. That wouldn’t be a hype spike, but a fundamental base reflecting reduced “going-concern” risk. Upside beyond that would depend on consistent positive quarters and any regulatory tailwinds, while failure to sustain cash flow would keep the stock closer to pre-breakeven levels.
2 · Reply
InvertedNegG
InvertedNegG Feb. 3 at 1:27 AM
$CWBHF What “modest, stable revenue” means for CWBHF For Charlotte’s Web (CWBHF), “modest, stable revenue” does not mean a return to peak growth or a major demand surge. It means holding annual revenue in roughly the $70–85 million range. Based on the company’s current, leaner cost structure: Below ~$65M: still cash-flow negative ~$70–75M: near breakeven ~$80M+: sustainably cash-flow positive (assuming margins hold) This level is achievable with low single-digit growth or even flat revenue, as long as declines stop and demand stabilizes. Medicare or federal CBD reimbursement is an upside catalyst, but only $5–10M in incremental revenue could be enough to push the company into positive cash flow. Bottom line: CWBHF doesn’t need a comeback story — it needs boring, stable revenue at the right scale. That’s why 2026 is a credible inflection year.
0 · Reply
InvertedNegG
InvertedNegG Feb. 3 at 1:23 AM
$CWBHF Federal CBD policy and Medicare pilot programs are upside catalysts, not requirements. Even without a major regulatory expansion, late-2026 cash-flow positivity remains plausible. If reimbursement or federal clarity accelerates, breakeven could arrive sooner. Base case: near breakeven in early 2026, first clearly positive cash-flow quarter in Q3 or Q4. Upside case: regulatory tailwinds pull that timeline forward. Downside case: weaker demand delays breakeven into early 2027. Bottom line: 2026 is the right year to watch. Cash-flow positivity is no longer speculative — it’s achievable, though not guaranteed.
0 · Reply